Sam Bankman-Fried’s Legal Team Demands ADHD Medication in Filing

• Sam Bankman-Fried’s legal team is demanding the FTX founder’s access to ADHD medication.
• Mark Cohen noted that the lack of Adderall can affect Bankman-Fried’s testimony.
• While Judge Kaplan revoked Bankman-Fried’s bail in August, he allowed treatment for ADHD and depression.

The legal team defending FTX founder Sam Bankman-Fried is negotiating to access his ADHD medication, Adderall. As Bankman-Fried’s criminal trial in a New York court rolls into its third week, legal representative Mark Cohen expressed that the challenge of ensuring his client receives a sufficient quantity of Adderall is impeding the defense team’s capacity to fight their case.

In a court filing from Sunday, October 15, Cohen highlighted that the lack of attention deficit hyperactivity disorder (ADHD) medication may have a significant impact on whether Bankman-Fried can “meaningfully participate” in the trial. Furthermore, he penned, “Mr. Bankman-Fried has been doing his best to remain focused during the trial for the past two weeks.”

As per earlier court documents, Bankman-Fried has been consuming Adderall tablets three to four times daily over the past three years. His le…

The post Sam Bankman-Fried’s Legal Team Demands ADHD Medication in Filing appeared first on Coin Edition.